Review



modified pbluescript ii ks (+) vector  (Agilent technologies)


Bioz Verified Symbol Agilent technologies is a verified supplier
Bioz Manufacturer Symbol Agilent technologies manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Agilent technologies modified pbluescript ii ks (+) vector
    Modified Pbluescript Ii Ks (+) Vector, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/modified pbluescript ii ks (+) vector/product/Agilent technologies
    Average 90 stars, based on 1 article reviews
    modified pbluescript ii ks (+) vector - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    plasmid vector pbluescript ii  (ATCC)
    93
    ATCC plasmid vector pbluescript ii
    Construction scheme for the cloning plasmid <t>pBluescript</t> I with restriction sites and fragments of the factor VIII gene: gene fragment from vector IOH10704, gene fragments A–C; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of blood coagulation factor VIII (Vector NTI AdvanceTM10)
    Plasmid Vector Pbluescript Ii, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plasmid vector pbluescript ii/product/ATCC
    Average 93 stars, based on 1 article reviews
    plasmid vector pbluescript ii - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    pbluescript ii ks vector  (New England Biolabs)
    96
    New England Biolabs pbluescript ii ks vector
    Construction scheme for the cloning plasmid <t>pBluescript</t> I with restriction sites and fragments of the factor VIII gene: gene fragment from vector IOH10704, gene fragments A–C; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of blood coagulation factor VIII (Vector NTI AdvanceTM10)
    Pbluescript Ii Ks Vector, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pbluescript ii ks vector/product/New England Biolabs
    Average 96 stars, based on 1 article reviews
    pbluescript ii ks vector - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    pbluescript ii ks (+) transcription vector  (GenScript corporation)
    90
    GenScript corporation pbluescript ii ks (+) transcription vector
    Construction scheme for the cloning plasmid <t>pBluescript</t> I with restriction sites and fragments of the factor VIII gene: gene fragment from vector IOH10704, gene fragments A–C; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of blood coagulation factor VIII (Vector NTI AdvanceTM10)
    Pbluescript Ii Ks (+) Transcription Vector, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pbluescript ii ks (+) transcription vector/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    pbluescript ii ks (+) transcription vector - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    modified pbluescript ii ks (+) vector  (Agilent technologies)
    90
    Agilent technologies modified pbluescript ii ks (+) vector
    Construction scheme for the cloning plasmid <t>pBluescript</t> I with restriction sites and fragments of the factor VIII gene: gene fragment from vector IOH10704, gene fragments A–C; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of blood coagulation factor VIII (Vector NTI AdvanceTM10)
    Modified Pbluescript Ii Ks (+) Vector, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/modified pbluescript ii ks (+) vector/product/Agilent technologies
    Average 90 stars, based on 1 article reviews
    modified pbluescript ii ks (+) vector - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    bamhi digested pbluescript ii ks vector  (New England Biolabs)
    99
    New England Biolabs bamhi digested pbluescript ii ks vector
    Construction scheme for the cloning plasmid <t>pBluescript</t> I with restriction sites and fragments of the factor VIII gene: gene fragment from vector IOH10704, gene fragments A–C; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of blood coagulation factor VIII (Vector NTI AdvanceTM10)
    Bamhi Digested Pbluescript Ii Ks Vector, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bamhi digested pbluescript ii ks vector/product/New England Biolabs
    Average 99 stars, based on 1 article reviews
    bamhi digested pbluescript ii ks vector - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    pbluescript ii ks+ vector  (Agilent technologies)
    90
    Agilent technologies pbluescript ii ks+ vector
    Construction scheme for the cloning plasmid <t>pBluescript</t> I with restriction sites and fragments of the factor VIII gene: gene fragment from vector IOH10704, gene fragments A–C; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of blood coagulation factor VIII (Vector NTI AdvanceTM10)
    Pbluescript Ii Ks+ Vector, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pbluescript ii ks+ vector/product/Agilent technologies
    Average 90 stars, based on 1 article reviews
    pbluescript ii ks+ vector - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    pbluescript® ii ks+vector  (Agilent technologies)
    90
    Agilent technologies pbluescript® ii ks+vector
    Construction scheme for the cloning plasmid <t>pBluescript</t> I with restriction sites and fragments of the factor VIII gene: gene fragment from vector IOH10704, gene fragments A–C; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of blood coagulation factor VIII (Vector NTI AdvanceTM10)
    Pbluescript® Ii Ks+Vector, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pbluescript® ii ks+vector/product/Agilent technologies
    Average 90 stars, based on 1 article reviews
    pbluescript® ii ks+vector - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Construction scheme for the cloning plasmid pBluescript I with restriction sites and fragments of the factor VIII gene: gene fragment from vector IOH10704, gene fragments A–C; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of blood coagulation factor VIII (Vector NTI AdvanceTM10)

    Journal: BioTechnologia

    Article Title: Expression of the gene encoding blood coagulation factor VIII without domain B in E. coli bacterial expression system

    doi: 10.5114/bta.2023.130728

    Figure Lengend Snippet: Construction scheme for the cloning plasmid pBluescript I with restriction sites and fragments of the factor VIII gene: gene fragment from vector IOH10704, gene fragments A–C; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of blood coagulation factor VIII (Vector NTI AdvanceTM10)

    Article Snippet: The plasmid vector pBluescript II (GenBank Accession No. ATCC 87047) carries the ColE1 replicon and the ampicillin resistance gene (ampR).

    Techniques: Cloning, Plasmid Preparation, Mutagenesis, Sequencing, Coagulation

    Primers for the construction of the cloning plasmid pBluescript I

    Journal: BioTechnologia

    Article Title: Expression of the gene encoding blood coagulation factor VIII without domain B in E. coli bacterial expression system

    doi: 10.5114/bta.2023.130728

    Figure Lengend Snippet: Primers for the construction of the cloning plasmid pBluescript I

    Article Snippet: The plasmid vector pBluescript II (GenBank Accession No. ATCC 87047) carries the ColE1 replicon and the ampicillin resistance gene (ampR).

    Techniques: Cloning, Plasmid Preparation

    Construction scheme for the cloning plasmid pBluescript + Fragment 1 + Fragment 2 + Fragment 3; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of the blood coagulation factor VIII; AmpR – ampicillin resistance gene, ori – origin of replication (Vector NTI AdvanceTM10)

    Journal: BioTechnologia

    Article Title: Expression of the gene encoding blood coagulation factor VIII without domain B in E. coli bacterial expression system

    doi: 10.5114/bta.2023.130728

    Figure Lengend Snippet: Construction scheme for the cloning plasmid pBluescript + Fragment 1 + Fragment 2 + Fragment 3; site-directed mutagenesis was necessary in order to change restriction sites into the original sequence of the blood coagulation factor VIII; AmpR – ampicillin resistance gene, ori – origin of replication (Vector NTI AdvanceTM10)

    Article Snippet: The plasmid vector pBluescript II (GenBank Accession No. ATCC 87047) carries the ColE1 replicon and the ampicillin resistance gene (ampR).

    Techniques: Cloning, Plasmid Preparation, Mutagenesis, Sequencing, Coagulation